| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Esperion Therapeutics, Inc. (ESPR) has 9 insiders with recent SEC Form 4 filings, including 7 buys and 5 sells. ESPR is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.47M | $4.65M | - | |
| CFO | 467.5K | $1.48M | - | |
| Other | 385.9K | $1.22M | - | |
| Other | 380.0K | $1.20M | - | |
| Dir | 177.5K | $561.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 28, 2019 | Mayleben Timothy M | President &CEO | Buy | 5,000 | $46.00 | $230,000.00 | +8.2% | |
| Apr 3, 2019 | Bartram Richard | Chief Financial Officer | Sell | 8,000 | $42.88 | $343,045.00 | -25.2% | |
| Mar 29, 2019 | Mayleben Timothy M | President &CEO | Buy | 5,000 | $40.00 | $200,000.00 | +8.9% | |
| Mar 20, 2019 | Mayleben Timothy M | President &CEO | Buy | 5,000 | $43.48 | $217,400.00 | +9.8% | |
| Mar 19, 2019 | Vitullo Nicole | Director | Sell | 15,329 | $44.73 | $685,596.14 | -90.0% | |
| Mar 14, 2019 | Mayleben Timothy M | President &CEO | Buy | 5,000 | $48.73 | $243,650.00 | +10.8% | |
| Mar 14, 2019 | Biotech Target N V55 | 10% Owner | Buy | 50,000 | $49.89 | $2,494,355.00 | +1.4% | |
| Mar 12, 2019 | Newton Roger S | Director | Sell | 25,000 | $50.06 | $1,251,500.00 | -4.4% | |
| Jan 4, 2019 | Biotech Target N V55 | 10% Owner | Buy | 80,000 | $41.29 | $3,303,256.00 | +2.4% | |
| Dec 24, 2018 | Biotech Target N V55 | 10% Owner | Buy | 50,000 | $39.91 | $1,995,725.00 | +1.5% |